BAX Baxter International, Inc.

NYSE
$26.42

Baxter International, Inc. (BAX) is expected to report earnings on January 28, 2027, before the market open. The consensus earnings estimate is $0.60 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.6% since its last earnings release on October 29, 2026.

Baxter International Beat Expectations, Narrows Guidance
Thursday, October 29, 2026 · 7:15 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 7:15 AM ET
Earnings Whisper
-
vs $0.60
Rev est $3.09B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $24.78

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Baxter International, Inc.

Baxter International Inc is a healthcare company. It develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic conditions.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.